Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease

Journal of Perinatology volume 35, pages 158–160 (2015)Cite this article

Subjects

Abstract

Macrophage activation syndrome (MAS) is a complication of rheumatic disorders characterized by cytopenia, multiple organ dysfunction and coagulopathy associated with an inappropriate activation of macrophage. In neonatal lupus erythematosus, MAS is rare but fatal, requiring early diagnosis and treatment for optimal outcome. We report a case of MAS in a neonate born to a mother with autoimmune disease, improved by treatment with steroid, intravenous immunoglobulin and cyclosporine.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Deane S, Selmi C, Teuber SS, Gershwin ME . Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010; 153: 109–120.

    Article  CAS  Google Scholar 

  2. Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH et al. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol 2012; 31: 1223–1230.

    Article  Google Scholar 

  3. Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009; 60: 3388–3399.

    Article  CAS  Google Scholar 

  4. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124–131.

    Article  Google Scholar 

  5. Deane S, Selmi C, Teuber SS, Gershwin ME . Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010; 153 (2): 109–120.

    Article  CAS  Google Scholar 

  6. Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J . Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 2011; 40 (1): 27–41.

    Article  CAS  Google Scholar 

  7. Suzuki Y, Takahashi N, Yada Y, Koike Y, Matano M, Nishimura H et al. Hemophagocytic lymphohistiocytosis in a newborn infant born to a mother with Sjogren syndrome antibodies. J Perinatol 2013; 33: 569–571.

    Article  CAS  Google Scholar 

  8. Buyon JP, Clancy RM . Neonatal lupus syndromes. Curr Opin Rheumatol 2003; 15: 535–541.

    Article  CAS  Google Scholar 

  9. Liu J, Yang YH, Lin YT, Chiang BL . Clinical characteristics of neonatal lupus erythematosus. J Microbiol Immunol Infect 2001; 34: 265–268.

    CAS  PubMed  Google Scholar 

  10. Roberts I, Murray NA . Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003; 88: F359–F364.

    Article  CAS  Google Scholar 

  11. Freeman HR, Ramanan AV . Review of haemophagocytic lymphohistiocytosis. Arch Dis Child 2011; 96: 688–693.

    Article  CAS  Google Scholar 

  12. Shander A, Cappellini MD, Goodnough LT . Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang 2009; 97: 185–197.

    Article  CAS  Google Scholar 

  13. Shander A, Sazama K . Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy. Transfusion 2010; 50: 1144–1155.

    Article  CAS  Google Scholar 

  14. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S . Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol 2004; 14: 205–215.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, College of Medicine, The Catholic University of Korea, Yeouido St. Mary’s Hospital, Seoul, Republic of Korea,

    J H Park, S H Kim, H J Kim, S J Lee, D C Jeong & S Y Kim

Authors
  1. J H Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S H Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S J Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D C Jeong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Y Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Y Kim.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, J., Kim, S., Kim, H. et al. Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease. J Perinatol 35, 158–160 (2015). https://doi.org/10.1038/jp.2014.207

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.207

This article is cited by

Search

Advanced search

Quick links